Association between changes in prices and out-of-pocket costs for brand-name clinician-administered drugs.

ABSTRACT:

Objective

To determine whether annual changes in prices for clinician-administered drugs are associated with changes in patient out-of-pocket costs.

Data sources and study setting

National commercial claims database, 2009 to 2018.

Study design

In a serial, cross-sectional study, we calculated the annual percent change in manufacturer list prices and net prices after rebates. We used two-part generalized linear models to assess the relationship between annual changes in price with (1) the percentage of individuals incurring any out-of-pocket costs and (2) the percent change in median non-zero out-of-pocket costs.

Data collection/extraction methods

We created annual cohorts of privately insured individuals who used one of 52 brand-name clinician-administered drug

SUBMITTER: Lalani HS 

PROVIDER: S-EPMC11622338 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature